(HealthDay News) – Recommendations for routine use of seasonal influenza vaccine in children have been updated, according to an American Academy of Pediatrics (AAP) policy statement published online Sept. 2 in Pediatrics.
Michael T. Brady, MD, from the AAP’s Committee on Infectious Diseases, and colleagues have updated the recommendations for routine use of seasonal influenza vaccine and use of antivirals for prevention and treatment of influenza in children.
The trivalent vaccine for the 2013–2014 season includes A/California/7/2009 (H1N1) pdm09-like virus (same as 2012–2013); an A/Texas/50/2012 (H3N2) virus (antigenically like the 2012–2013 strain); and a B/Massachusetts/2/2012-like virus (a B/Yamagata lineage like 2012–2013 but a different virus). The U.S. Food and Drug Administration has licensed a quadrivalent vaccine containing an additional B virus (B/Brisbane/60/2008-like virus [B/Victoria lineage]). The trivalent or quadrivalent vaccine is indicated for annual universal influenza administration, with no preference for the trivalent or quadrivalent vaccine. For children aged 6 months through 8 years, the dosing algorithm of administration of influenza vaccine is unchanged from 2012–2013.
“As always, pediatricians, nurses, and all health care personnel should promote influenza vaccine use and infection control measures,” the authors write. “In addition, pediatricians should promptly identify influenza infections to enable rapid antiviral treatment, when indicated, to reduce morbidity and mortality.”